United Therapeutics UTHR Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's operating cash flow?
- United Therapeutics (UTHR) reported operating cash flow of $463.3M in Q1 2026.
- How has United Therapeutics's operating cash flow changed year-over-year?
- United Therapeutics's operating cash flow increased by 0.5% year-over-year, from $461.2M to $463.3M.
- What is the long-term trend for United Therapeutics's operating cash flow?
- Over 4 years (2021 to 2025), United Therapeutics's operating cash flow has grown at a 27.1% compound annual growth rate (CAGR), from $598.2M to $1.56B.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.